Globus Medical (GMED) Tops Q1 EPS by 2c, Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Join SI Premium – FREE
Globus Medical (NYSE: GMED) reported Q1 EPS of $0.26, $0.02 better than the analyst estimate of $0.24. Revenue for the quarter came in at $131.6 million versus the consensus estimate of $122.3 million.
Globus Medical sees FY2015 EPS of $1.02, versus the consensus of $1.02. Globus Medical sees FY2015 revenue of $514 million, versus the consensus of $511.64 million.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kosmos Energy (KOS) Misses Q3 EPS by 3c
- nVent Electric (NVT) Tops Q3 EPS by 13c ; Offers Guidance
- Dominion Energy (D) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
